SB 258719 hydrochlorideSelective 5-HT7 antagonist CAS# 1217674-10-6 |
2D Structure
- Skepinone-L
Catalog No.:BCC1953
CAS No.:1221485-83-1
- SB202190 (FHPI)
Catalog No.:BCC1093
CAS No.:152121-30-7
- SD-06
Catalog No.:BCC1937
CAS No.:271576-80-8
- BIRB 796 (Doramapimod)
Catalog No.:BCC2535
CAS No.:285983-48-4
- LY2228820
Catalog No.:BCC2528
CAS No.:862507-23-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1217674-10-6 | SDF | Download SDF |
PubChem ID | 56972181 | Appearance | Powder |
Formula | C18H31ClN2O2S | M.Wt | 374.97 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in water and to 100 mM in DMSO | ||
Chemical Name | N,3-dimethyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]benzenesulfonamide;hydrochloride | ||
SMILES | CC1CCN(CC1)CCC(C)N(C)S(=O)(=O)C2=CC=CC(=C2)C.Cl | ||
Standard InChIKey | UIZKHTBWJSUGOV-UNTBIKODSA-N | ||
Standard InChI | InChI=1S/C18H30N2O2S.ClH/c1-15-8-11-20(12-9-15)13-10-17(3)19(4)23(21,22)18-7-5-6-16(2)14-18;/h5-7,14-15,17H,8-13H2,1-4H3;1H/t17-;/m1./s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective 5-HT7 receptor antagonist that displays > 100-fold selectivity over a range of other receptors. Reverses the hypothermic effect of 5-CT in mice following i.p. administration. |
SB 258719 hydrochloride Dilution Calculator
SB 258719 hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6669 mL | 13.3344 mL | 26.6688 mL | 53.3376 mL | 66.672 mL |
5 mM | 0.5334 mL | 2.6669 mL | 5.3338 mL | 10.6675 mL | 13.3344 mL |
10 mM | 0.2667 mL | 1.3334 mL | 2.6669 mL | 5.3338 mL | 6.6672 mL |
50 mM | 0.0533 mL | 0.2667 mL | 0.5334 mL | 1.0668 mL | 1.3334 mL |
100 mM | 0.0267 mL | 0.1333 mL | 0.2667 mL | 0.5334 mL | 0.6667 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- SB 205607 dihydrobromide
Catalog No.:BCC5687
CAS No.:1217628-73-3
- BYL-719
Catalog No.:BCC3707
CAS No.:1217486-61-7
- threo-1-C-Syringylglycerol
Catalog No.:BCN6110
CAS No.:121748-11-6
- NAS-181
Catalog No.:BCC7056
CAS No.:1217474-40-2
- (+)-UH 232 maleate
Catalog No.:BCC6790
CAS No.:1217473-50-1
- Isochandalone
Catalog No.:BCN4767
CAS No.:121747-90-8
- Isoderrone
Catalog No.:BCN3698
CAS No.:121747-89-5
- Ro 26-4550 trifluoroacetate
Catalog No.:BCC5813
CAS No.:1217448-66-2
- VD2-D3
Catalog No.:BCC2034
CAS No.:1217448-46-8
- A 350619 hydrochloride
Catalog No.:BCC5939
CAS No.:1217201-17-6
- CP 31398 dihydrochloride
Catalog No.:BCC2406
CAS No.:1217195-61-3
- 6-O-p-Methoxycinnamoylcatalpol
Catalog No.:BCN6109
CAS No.:121710-02-9
- RS 16566 dihydrochloride
Catalog No.:BCC6890
CAS No.:1217788-97-0
- 5-Iodo-A-85380 dihydrochloride
Catalog No.:BCC7099
CAS No.:1217837-17-6
- Ac-Trp-OH
Catalog No.:BCC3109
CAS No.:1218-34-4
- Xylometazoline HCl
Catalog No.:BCC4879
CAS No.:1218-35-5
- Pidotimod
Catalog No.:BCC4823
CAS No.:121808-62-6
- CAY10505
Catalog No.:BCC4990
CAS No.:1218777-13-9
- LDE225 Diphosphate
Catalog No.:BCC1693
CAS No.:1218778-77-8
- GKT137831
Catalog No.:BCC5460
CAS No.:1218942-37-0
- Dorsomorphin 2HCl
Catalog No.:BCC4361
CAS No.:1219168-18-9
- (-)-MK 801
Catalog No.:BCC4593
CAS No.:121917-57-5
- CCT 031374 hydrobromide
Catalog No.:BCC6258
CAS No.:1219184-91-4
- Aurothioglucose
Catalog No.:BCC5446
CAS No.:12192-57-3
The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor.[Pubmed:12763096]
Neuropharmacology. 2003 Jun;44(8):1031-7.
The 5-HT(7) receptor is a recent addition to the 5-HT receptor family and to date there is no clear idea as to its potential role in the CNS. The receptor has been mapped by in situ hybridization and 5-HT(7)-like immunoreactivity and has been detected in discrete areas of the brain including the hypothalamus (Oliver et al., 1999). This suggests the receptor may be involved in temperature regulation and have shown that a selective 5-HT(7) receptor antagonist reverses the hypothermic effect of 5-CT in guinea-pigs. The current study confirmed that the 5-HT(7) receptor antagonists, SB-269970 (1-30 mg/kg, i.p.) and SB-258719 (5-20 mg/kg, i.p.), but not the 5-HT(1A) receptor antagonist, WAY 100635(0.1-1 mg/kg, s.c.), or the 5-HT(1B/D) antagonist, GR127935 (1.25-5 mg/kg, i.p.), reversed the hypothermic effect of 5-CT in mice. In addition the effect of 5-CT on body temperature was examined on 5-HT(7) receptor null mutant mice. 5-CT (0.1-1 mg/kg, i.p.) significantly reduced rectal temperature in wildtype but not 5-HT(7) receptor knockout mice. This suggests that the hypothermic effects of 5-CT are mediated through the 5-HT(7) receptor. All procedures were carried out in accordance with the UK Animals (Scientific Procedures) Act (1986).
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.[Pubmed:9720804]
Br J Pharmacol. 1998 Jul;124(6):1300-6.
1. The functional profile of the long form of the human cloned 5-HT7 receptor (designated h5-HT7(a)) was investigated using a number of 5-HT receptor agonists and antagonists and compared with its binding profile. Receptor function was measured using adenylyl cyclase activity in washed membranes from HEK293 cells stably expressing the recombinant h5-HT7(a) receptor. 2. The receptor binding profile, determined by competition with [3H]-5-CT, was consistent with that previously reported for the h5-HT7(a) receptor. The selective 5-HT7 receptor antagonist SB-258719 ((R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]ben zene sulfonamide) displayed high affinity (pKi 7.5) for the receptor. 3. In the adenylyl cyclase functional assay, 5-CT and 8-OH-DPAT were both full agonists compared to 5-HT and the rank order of potency for agonists (5-CT > 5-HT > 8-OH-DPAT) was the same in functional and binding studies. 4. Risperidone, methiothepin, mesulergine, clozapine, olanzapine, ketanserin and SB-258719 antagonised surmountably 5-CT-stimulated adenylyl cyclase activity. Schild analysis of the antagonism by SB-258719 gave a pA2 of 7.2+/-0.2 and slope not significantly different from 1, consistent with competitive antagonism. 5. The same antagonists also inhibited basal adenylyl cyclase activity with a rank order of potency in agreement with those for antagonist potency and binding affinity. Both SB-258719 and mesulergine displayed apparent partial inverse agonist profiles compared to the other antagonists tested. These inhibitory effects of antagonists appear to be 5-HT7 receptor-mediated and to reflect inverse agonism. 6. It is concluded that in this expression system, the h5-HT7(a) receptor shows the expected binding and functional profile and displays constitutive activity, revealing inverse agonist activity for a range of antagonists.